(1992) Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu
NMRI, Naval Medical Research Institute
As a GLP-1 receptor agonist, Wegovy targets brain regions that regulate appetite and food intake, focusing on long-term solutions rather than temporary fixes
Trials have demonstrated that the latest basal analogues may cause less hypoglycaemia than first-generation basal analogues and NPH insulin, while rapid-acting analogues achieve better mealtime coverage and less post-meal hypoglycaemia than short-acting (regular) human insulin [87, 88]
Anti-Inflammatory: Reduces oxidative stress and inflammation
124 The dual GLP-1/GIP receptor agonist tirzepatide ameliorated AD pathology in diabetic rat models by improving learning and memory, modulating cerebral glucose metabolism, promoting neurotrophic factor expression, and suppressing inflammatory responses